Annual ROE:
-46.20%+3.05%(+6.19%)Summary
- As of today, NAMS annual return on equity is -46.20%, with the most recent change of +3.05% (+6.19%) on December 31, 2024.
- During the last 3 years, NAMS annual ROE has fallen by -49.43% (-1530.34%).
- NAMS annual ROE is now -1530.34% below its all-time high of 3.23%, reached on December 31, 2021.
Performance
NAMS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
-32.32%-5.42%(-20.15%)Summary
- As of today, NAMS quarterly return on equity is -32.32%, with the most recent change of -5.42% (-20.15%) on September 30, 2025.
- Over the past year, NAMS quarterly ROE has increased by +21.33% (+39.76%).
- NAMS quarterly ROE is now -1103.73% below its all-time high of 3.22%, reached on December 31, 2021.
Performance
NAMS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
NAMS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +6.2% | +39.8% |
| 3Y3 Years | -1530.3% | -1062.6% |
| 5Y5 Years | -10000.0% | -10000.0% |
NAMS ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -1530.3% | +6.2% | -1062.6% | +44.8% |
| 5Y | 5-Year | -1530.3% | +6.2% | -1103.7% | +44.8% |
| All-Time | All-Time | -1530.3% | +6.2% | -1103.7% | +44.8% |
NAMS ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | -32.32%(-20.1%) |
| Jun 2025 | - | -26.90%(+22.1%) |
| Mar 2025 | - | -34.53%(+41.0%) |
| Dec 2024 | -46.20%(+6.2%) | -58.56%(-9.2%) |
| Sep 2024 | - | -53.65%(+7.9%) |
| Jun 2024 | - | -58.23%(-10.8%) |
| Mar 2024 | - | -52.56%(-41.9%) |
| Dec 2023 | -49.25%(-511.0%) | - |
| Mar 2023 | - | -37.05% |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -8.06%(-349.5%) | - |
| Sep 2022 | - | -2.78%(-226.9%) |
| Jun 2022 | - | 2.19%(+4.3%) |
| Mar 2022 | - | 2.10%(-34.8%) |
| Dec 2021 | 3.23%(>+9900.0%) | 3.22%(+26.8%) |
| Sep 2021 | - | 2.54%(+109.9%) |
| Jun 2021 | - | 1.21%(-45.5%) |
| Mar 2021 | - | 2.22%(+7300.0%) |
| Dec 2020 | 0.03% | 0.03% |
FAQ
- What is NewAmsterdam Pharma Company N.V. annual return on equity?
- What is the all-time high annual ROE for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. annual ROE year-on-year change?
- What is NewAmsterdam Pharma Company N.V. quarterly return on equity?
- What is the all-time high quarterly ROE for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. quarterly ROE year-on-year change?
What is NewAmsterdam Pharma Company N.V. annual return on equity?
The current annual ROE of NAMS is -46.20%
What is the all-time high annual ROE for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high annual return on equity is 3.23%
What is NewAmsterdam Pharma Company N.V. annual ROE year-on-year change?
Over the past year, NAMS annual return on equity has changed by +3.05% (+6.19%)
What is NewAmsterdam Pharma Company N.V. quarterly return on equity?
The current quarterly ROE of NAMS is -32.32%
What is the all-time high quarterly ROE for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high quarterly return on equity is 3.22%
What is NewAmsterdam Pharma Company N.V. quarterly ROE year-on-year change?
Over the past year, NAMS quarterly return on equity has changed by +21.33% (+39.76%)